INFOGRAPHIC

Southern Philippines Medical Center Heart Institute surgical services from 2008 to 2017

SPMC J Health Care Serv. 2018;4(1):5 ARK: http://n2t.net/ark:/76951/jhcs48v9dd

Mark Angelo Andrada,1 Clarence Xlasi Ladrero2


1Infection Prevention and Control Unit, Department of Internal Medicine, Southern Philippines Medical Center, JP Laurel Ave, Davao City
2Hospital Research and Publication Office, Southern Philippines Medical Center, JP Laurel Ave, Davao City

Correspondence Mark Angelo Andrada, markandrada123@gmail.com

Article editor Yasmin M Avila

Received 29 June 2018

Accepted 13 August 2018

Cite as Andrada MA, Ladrero CX. Southern Philippines Medical Center Heart Institute surgical services from 2008 to 2017. SPMC J Health Care Serv. 2017;4(1):5. http://n2t.net/ark:/76951/jhcs48v9dd

The Mindanao Heart Center (MHC) was inaugurated on 14 February 2007. On 10 October 2013, through Hospital Administration No. 174 series of 2013, MHC was renamed Southern Philippines Medical Center Heart Institute (SPMCHI). The Institute offers a wide range of cardiovascular medical and surgical services, including major heart surgeries such as ventricular septal defect (VSD) repair, tetralogy of Fallot (TOF) correction, and coronary artery bypass graft (CABG).


On 3 July 2012, the Philippine Health Insurance Corporation (PHIC) launched the Case Type Z Benefit Package (ZBP), a health financing scheme for patients with medical conditions that are classified as economically and medically catastrophic.1 ZBP covers all expenses for the essential diagnostic and therapeutic management of patients with these conditions. Initially, ZBP only covered the expenses for acute lymphocytic lymphoblastic leukemia in children, early stage breast cancer, low to intermediate prostate cancer and kidney transplant for end-stage renal disease.2 In February 2013, the PHIC included standard-risk CABG, total correction of TOF, and surgical closure of VSD in the list of surgical procedures covered by ZBP.3


To qualify for ZBP coverage, patients for VSD and TOF correction should be at least 1 to 10 years old.4 Moreover, these patients should not have any history of heart surgeries or stenting, associated congenital heart defects, or other comorbidities, and their New York Heart Association functional classification must be class I to II. Adults for CABG should be at least 19 years old. They must pass prior non-invasive viability tests and must have stable coronary artery disease with indication for CABG, based on coronary anatomy, severity of symptoms, and left ventricular function. Furthermore, they should not have any history of cardiothoracic surgeries through median sternotomy or any prior transcutaneous cardiac interventions within 30 days prior to the CABG procedure.


While SPMCHI has been performing heart surgeries since shortly after it was established, the first heart surgery performed in the Institution under ZBP only happened in April 2014. To date, a total of 157 VSD repairs, 61 TOF corrections, and 369 CABG procedures have been performed in SPMCHI. From 2014 to 2017, annual ZBP coverage was (71/112) 63.39% for VSD, (24/41) 58.54% for TOF and (93/229) 40.61% for CABG. In general, the census for these heart surgeries has been increasing each year since PHIC started to offer the ZBP to eligible patients, indicating that the package has helped provide health care access among patients with economically catastrophic cardiovascular illnesses.



Infographic

Acknowledgments

We would like to thank Ms Rhialyn Dumaquita and Ms Lani Paler of the Southern Philippines Medical Center (SPMC) Hospital Information Management Department, Ms Encarnacion Tabanao and Dr Federico Fuente of the SPMC Billing Section, Ms Vanessa Saren of Segworks Technologies Corporation, Mr Shandy Mar Tabanao of SPMC Integrated Hospital Operations and Management Program, Ms Charity L Mata, nursing head of SPMC Operating Room, Ms Maria Victoria Javonillo, clinical coordinator of the SPMC Heart Institute (SPMC HI) Nursing Division, and Ms Arcelyn Justol, Mr Neill Stephen Nacua and Dr Mark Edward Anthony Maruya of SPMC HI for providing the data and information used in this report.


Article source

Commissioned


Peer review

Internal


Competing interests

None declared


Access and license

This is an Open Access article licensed under the Creative Commons Attribution-NonCommercial 4.0 International License, which allows others to share and adapt the work, provided that derivative works bear appropriate citation to this original work and are not used for commercial purposes. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc/4.0/

References

1. Philippine Health Insurance Corporation. Governing Policies on PhilHealth Benefit Package for Case Type Z . PhilHealth Circular No. 029 s2012.


2. Philippine Health Insurance Corporation. Case Type Z Benefit Package for Acute Lymphocytic (Lymphoblastic) Leukemia (ALL), Breast Cancer, Prostate Cancer and Kidney Transplant. PhilHealth Circular No. 030 s2012.


3. Philippine Health Insurance Corporation. Z Benefit package rates for Coronary Artery Bypass Graft surgery, surgery for Tetralogy of Fallot, surgery for Ventricular Septal Defect and Cervical Cancer. PhilHealth Circular No. 002 s2013.


4. Philippine Health Insurance Corporation.The guiding principles of the Z Benefits. PhilHealth Circular No. 035 s2015.

Copyright © 2018 MA Andrada, et al.

     

Published
August 15, 2018

Issue
Volume 4 Issue 1 (2018)

Section
Infographic


Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International License that allows others to share the work for non-commercial purposes with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional, non-commercial contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors grant the journal permission to rewrite, edit, modify, store and/or publish the submission in any medium or format a version or abstract forming part thereof, all associated supplemental materials, and subsequent errata, if necessary, in a publicly available publication or database.
  4. Authors warrant that the submission is original with the authors and does not infringe or transfer any copyright or violate any other right of any third parties.